Performance of a Genomic Sequencing Classifier for the Preoperative Diagnosis of Cytologically Indeterminate Thyroid Nodules
Kepal N. Patel(NYU Langone Health), Paul W. Ladenson(Johns Hopkins Medicine), Gregory W. Randolph(Massachusetts Eye and Ear Infirmary), Virginia A. LiVolsi(Hospital of the University of Pennsylvania), Michael H. Shanik, Julie Ann Sosa(Duke University), Michael W. Yeh(University of California, Los Angeles), P. Sean Walsh(Veracyte (United States)), Peter M. Sadow(Massachusetts Eye and Ear Infirmary), S. Thomas Traweek, R. Mack Harrell, Quan‐Yang Duh(University of California, San Francisco), Trevor E. Angell(Harvard University), Richard T. Kloos(Veracyte (United States)), Ronald Ghossein, Joshua Babiarz(Veracyte (United States)), Jing Huang(Veracyte (United States)), Su Yeon Kim(Veracyte (United States)), Giulia C. Kennedy(Veracyte (United States)), Thomas Blevins(Texas Diabetes & Endocrinology), Duncan Whitney(Veracyte (United States)), Neil M. Barth(Veracyte (United States))
Cited by 379
Related Papers
Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma
|JAMA Oncology|2016|1.4k
Selumetinib-Enhanced Radioiodine Uptake in Advanced Thyroid Cancer
|New England Journal of Medicine|2013|825
2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer
|Thyroid|2021|699
<i>CXCL9:SPP1</i> macrophage polarity identifies a network of cellular programs that control human cancers
|Science|2023|607
A Comparison of Recombinant Human Thyrotropin and Thyroid Hormone Withdrawal for the Detection of Thyroid Remnant or Cancer1
|The Journal of Clinical Endocrinology & Metabolism|1999|564